CELLULAR & MOLECULAR BASIS FOR BASAL CELL NEVUS SYNDROME
蜂窝网络
基本信息
- 批准号:3195632
- 负责人:
- 金额:$ 9.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-07-09 至 1993-06-30
- 项目状态:已结题
- 来源:
- 关键词:6 thioguanine animal old age athymic mouse autosomal dominant trait basal cell carcinoma cell biology dimer disease /disorder proneness /risk fibroblasts human subject light adverse effect molecular biology nevus nonvisual photosensitivity ouabain preneoplastic state pyrimidines skin neoplasms solar radiation ultraviolet radiation
项目摘要
DESCRIPTION: (Adapted from the applicant's abstract) The long-term
objective of this proposal is to investigate the cellular and molecular
basis for the genetic predisposition to skin cancer of individuals with
BCNS. However, the current proposal deals solely with cellular aspects,
although future studies on molecular aspects are anticipated. BCNS is an
autosomal dominant genetic disorder in which the afflicted individuals are
predisposed to multiple basal cell nevi and basal cell carcinomas.
Preliminary studies have indicated that skin fibroblasts from BCNS
individuals are hypersensitive to killing by UV-B/A (280-400 nm), but not
UV-C (254 nm) radiation, compared to skin fibroblasts from normal
individuals. However, the excision repair of UV-B/A-induced pyrimidine
dimers was similar in BCNS and normal human skin fibroblasts. These
results suggest that the increased sensitivity of BCNS skin fibroblasts to
killing by UV-B/A radiation is not due to a defect in the excision repair
of pyrimidine dimers, but due to a defect in some other repair mechanism
involving either pyrimidine dimers or other, as yet, unidentified
photoproducts. The fact that UV-B radiation present in sunlight is known
to be responsible for the induction of most human skin cancers, together
with the investigators' observation that BCNS cells are hypersensitive to
killing by UV-B/A radiation, lend credence to the hypothesis that there may
be an association between hypersensitivity to killing by UV-B/A radiation
and genetic predisposition of individuals with BCNS to sunlight-induced
skin cancers.
The specific aims of this proposal are: (1) To measure the sensitivity (in
terms of survival) of BCNS and normal human skin fibroblasts and epidermal
cells to broad-band UV-B/A, UV-A, and monochromatic (297 nm, 302 nm, 313
nm, 334 nm, or 365 nm) radiations; and (2) to examine the repair kinetics
of UV-induced DNA damage in skin fibroblasts and epidermal cells from BCNS
and normal individuals. Cell survival will be assayed by colony forming
ability. The repair of pyrimidine dimers, (6-4) photoproducts and
single-strand breaks in the DNA will be measured at various times during
the post-UV recovery phase. The applicants state that an important aspect
of this revised application is to determine whether the epidermal cells
from BCNS patients also exhibit increased UV sensitivity and similar repair
defect(s) as skin fibroblasts. The experiments using epidermal cells, they
insist, are highly relevant because most skin cancers that arise in BCNS
patients are epidermal in origin. Studies addressing these questions may
lead to the identification of some of the defects that are associated with
the pathogenesis of skin cancer in BCNS patients.
描述:(改编自申请人的摘要)长期
本提案的目的是研究细胞和分子
患有皮肤癌的人患皮肤癌遗传易感性的基础
BCNS。 然而,当前的提议仅涉及蜂窝方面,
尽管对分子方面的未来研究是可预期的。 BCNS是一个
常染色体显性遗传疾病,其中患病个体是
易患多发性基底细胞痣和基底细胞癌。
初步研究表明,来自BCNS的皮肤成纤维细胞
个体对UV-B/A(280-400 nm)的杀伤过敏,但对
UV-C(254 nm)辐射,与正常皮肤成纤维细胞相比
个体 然而,UV-B/A诱导的嘧啶的切除修复
BCNS和正常人皮肤成纤维细胞中的二聚体相似。 这些
结果表明,BCNS皮肤成纤维细胞对
UV-B/A辐射的杀伤不是由于切除修复的缺陷
嘧啶二聚体,但由于其他一些修复机制的缺陷,
涉及嘧啶二聚体或其他尚未确定的
照片产品 太阳光中的UV-B辐射是已知的
与大多数人类皮肤癌的诱发有关,
研究人员观察到BCNS细胞对
紫外线B/A辐射的杀伤,使人们相信,
对UV-B/A辐射杀伤的超敏反应
和遗传易感性的个人与BCNS阳光诱导
皮肤癌
本建议的具体目的是:(1)测量敏感性(在
BCNS和正常人皮肤成纤维细胞和表皮细胞的存活率
细胞的宽带UV-B/A,UV-A,和单色(297 nm,302 nm,313
nm、334 nm或365 nm)辐射;以及(2)检查修复动力学
紫外线诱导的皮肤成纤维细胞和表皮细胞的DNA损伤
和正常的个体。 将通过集落形成来测定细胞存活率
能力 嘧啶二聚体、(6-4)光产物和
DNA中的单链断裂将在不同的时间测量,
紫外线后的恢复阶段。 申请人说,一个重要的方面是,
是为了确定表皮细胞是否
从BCNS患者也表现出增加的紫外线敏感性和类似的修复
皮肤成纤维细胞等缺陷。 使用表皮细胞的实验,
因为大多数皮肤癌发生在BCNS,
患者起源于表皮。 针对这些问题的研究可
导致识别出与以下方面相关的一些缺陷:
BCNS患者皮肤癌的发病机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HONNAVARA N. ANANTHASWAMY其他文献
HONNAVARA N. ANANTHASWAMY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HONNAVARA N. ANANTHASWAMY', 18)}}的其他基金
GENETIC ALTERATIONS IN PUVA INDUCED SKIN CANCERS
PUVA 诱发的皮肤癌的基因改变
- 批准号:
2633902 - 财政年份:1996
- 资助金额:
$ 9.46万 - 项目类别:
GENETIC ALTERATIONS IN PUVA INDUCED SKIN CANCERS
PUVA 诱发的皮肤癌的基因改变
- 批准号:
2110780 - 财政年份:1996
- 资助金额:
$ 9.46万 - 项目类别:
GENETIC ALTERATIONS IN PUVA INDUCED SKIN CANCERS
PUVA 引起的皮肤癌的基因改变
- 批准号:
2856393 - 财政年份:1996
- 资助金额:
$ 9.46万 - 项目类别:
GENETIC ALTERATIONS IN PUVA INDUCED SKIN CANCERS
PUVA 诱发的皮肤癌的基因改变
- 批准号:
2008832 - 财政年份:1996
- 资助金额:
$ 9.46万 - 项目类别:
PREDOCTORAL TRAINING PROGRAM IN CANCER IMMUNOBIOLOGY
癌症免疫生物学博士前培训计划
- 批准号:
6041181 - 财政年份:1994
- 资助金额:
$ 9.46万 - 项目类别:
PREDOCTORAL TRAINING PROGRAM IN CANCER IMMUNOBIOLOGY
癌症免疫生物学博士前培训计划
- 批准号:
6362504 - 财政年份:1994
- 资助金额:
$ 9.46万 - 项目类别:
PREDOCTORAL TRAINING PROGRAM IN CANCER IMMUNOBIOLOGY
癌症免疫生物学博士前培训计划
- 批准号:
6732160 - 财政年份:1994
- 资助金额:
$ 9.46万 - 项目类别:
PREDOCTORAL TRAINING PROGRAM IN CANCER IMMUNOBIOLOGY
癌症免疫生物学博士前培训计划
- 批准号:
6755518 - 财政年份:1994
- 资助金额:
$ 9.46万 - 项目类别:
PREDOCTORAL TRAINING PROGRAM IN CANCER IMMUNOBIOLOGY
癌症免疫生物学博士前培训计划
- 批准号:
6612165 - 财政年份:1994
- 资助金额:
$ 9.46万 - 项目类别:
PREDOCTORAL TRAINING PROGRAM IN CANCER IMMUNOBIOLOGY
癌症免疫生物学博士前培训计划
- 批准号:
6632841 - 财政年份:1994
- 资助金额:
$ 9.46万 - 项目类别: